vs

Side-by-side financial comparison of Nine Energy Service, Inc. (NINE) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

Nine Energy Service, Inc. is the larger business by last-quarter revenue ($132.2M vs $83.1M, roughly 1.6× PROCEPT BioRobotics Corp). Nine Energy Service, Inc. runs the higher net margin — -14.5% vs -38.1%, a 23.5% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs -6.5%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs -3.6%).

Xcel Energy Inc. is a U.S. regulated electric utility and natural gas delivery company based in Minneapolis, Minnesota, serving approximately 3.9 million electricity customers and 2.2 million natural gas customers across parts of eight states as of mid-2025. It consists of four operating subsidiaries: Northern States Power-Minnesota, Northern States Power-Wisconsin, Public Service Company of Colorado, and Southwestern Public Service Co.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

NINE vs PRCT — Head-to-Head

Bigger by revenue
NINE
NINE
1.6× larger
NINE
$132.2M
$83.1M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+26.7% gap
PRCT
20.2%
-6.5%
NINE
Higher net margin
NINE
NINE
23.5% more per $
NINE
-14.5%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
-3.6%
NINE

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
NINE
NINE
PRCT
PRCT
Revenue
$132.2M
$83.1M
Net Profit
$-19.2M
$-31.6M
Gross Margin
64.9%
Operating Margin
-4.2%
-4.1%
Net Margin
-14.5%
-38.1%
Revenue YoY
-6.5%
20.2%
Net Profit YoY
-117.4%
-27.9%
EPS (diluted)
$-0.47
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NINE
NINE
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$132.2M
$76.4M
Q3 25
$132.0M
$83.3M
Q2 25
$147.3M
$79.2M
Q1 25
$150.5M
$69.2M
Q4 24
$141.4M
$68.2M
Q3 24
$138.2M
$58.4M
Q2 24
$132.4M
$53.4M
Net Profit
NINE
NINE
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-19.2M
$-29.8M
Q3 25
$-14.6M
$-21.4M
Q2 25
$-10.4M
$-19.6M
Q1 25
$-7.1M
$-24.7M
Q4 24
$-8.8M
$-18.9M
Q3 24
$-10.1M
$-21.0M
Q2 24
$-14.0M
$-25.6M
Gross Margin
NINE
NINE
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
NINE
NINE
PRCT
PRCT
Q1 26
-4.1%
Q4 25
-4.2%
-40.6%
Q3 25
-0.9%
-27.8%
Q2 25
2.3%
-28.0%
Q1 25
3.7%
-39.7%
Q4 24
2.5%
-28.9%
Q3 24
1.8%
-38.4%
Q2 24
-1.1%
-50.3%
Net Margin
NINE
NINE
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-14.5%
-39.1%
Q3 25
-11.1%
-25.7%
Q2 25
-7.1%
-24.7%
Q1 25
-4.7%
-35.8%
Q4 24
-6.3%
-27.6%
Q3 24
-7.3%
-35.9%
Q2 24
-10.6%
-48.0%
EPS (diluted)
NINE
NINE
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$-0.47
$-0.54
Q3 25
$-0.35
$-0.38
Q2 25
$-0.25
$-0.35
Q1 25
$-0.18
$-0.45
Q4 24
$-0.21
$-0.34
Q3 24
$-0.26
$-0.40
Q2 24
$-0.40
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NINE
NINE
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$18.4M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$-115.0M
$347.7M
Total Assets
$339.5M
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NINE
NINE
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$18.4M
$286.5M
Q3 25
$14.4M
$294.3M
Q2 25
$14.2M
$302.7M
Q1 25
$17.3M
$316.2M
Q4 24
$27.9M
$333.7M
Q3 24
$15.7M
$196.8M
Q2 24
$26.0M
$214.1M
Total Debt
NINE
NINE
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
NINE
NINE
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$-115.0M
$365.9M
Q3 25
$-95.9M
$380.3M
Q2 25
$-81.7M
$385.8M
Q1 25
$-72.1M
$389.2M
Q4 24
$-66.1M
$402.2M
Q3 24
$-57.6M
$241.2M
Q2 24
$-49.7M
$251.8M
Total Assets
NINE
NINE
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$339.5M
$508.1M
Q3 25
$340.7M
$511.5M
Q2 25
$361.2M
$513.1M
Q1 25
$359.2M
$519.4M
Q4 24
$360.1M
$534.0M
Q3 24
$353.2M
$374.1M
Q2 24
$381.7M
$374.4M
Debt / Equity
NINE
NINE
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NINE
NINE
PRCT
PRCT
Operating Cash FlowLast quarter
$-2.2M
Free Cash FlowOCF − Capex
$-4.8M
FCF MarginFCF / Revenue
-3.6%
Capex IntensityCapex / Revenue
2.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-23.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NINE
NINE
PRCT
PRCT
Q1 26
Q4 25
$-2.2M
$-10.3M
Q3 25
$-9.9M
$-6.6M
Q2 25
$10.1M
$-15.0M
Q1 25
$-5.3M
$-17.0M
Q4 24
$15.0M
$-32.4M
Q3 24
$-5.8M
$-18.8M
Q2 24
$12.9M
$-15.7M
Free Cash Flow
NINE
NINE
PRCT
PRCT
Q1 26
Q4 25
$-4.8M
$-12.2M
Q3 25
$-13.4M
$-9.5M
Q2 25
$4.2M
$-17.8M
Q1 25
$-9.3M
$-18.8M
Q4 24
$11.8M
$-33.6M
Q3 24
$-9.3M
$-19.0M
Q2 24
$10.3M
$-16.8M
FCF Margin
NINE
NINE
PRCT
PRCT
Q1 26
Q4 25
-3.6%
-15.9%
Q3 25
-10.2%
-11.4%
Q2 25
2.9%
-22.5%
Q1 25
-6.2%
-27.2%
Q4 24
8.3%
-49.2%
Q3 24
-6.7%
-32.6%
Q2 24
7.7%
-31.4%
Capex Intensity
NINE
NINE
PRCT
PRCT
Q1 26
Q4 25
2.0%
2.4%
Q3 25
2.6%
3.4%
Q2 25
4.0%
3.5%
Q1 25
2.6%
2.7%
Q4 24
2.3%
1.7%
Q3 24
2.5%
0.4%
Q2 24
2.0%
2.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NINE
NINE

Cement$52.6M40%
Tool Revenue$28.6M22%
Coiled Tubing$25.8M20%
Wireline$25.1M19%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons